Search research articles
Contact Us
Filters
Showing results (111-120 of 129) with videos related to
Page
of 13
Sort By:
The Journal of Experimental Medicine
|
September 5, 2002
Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response
Matthias Ernst, Melissa Inglese, Glen M Scholz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 12, 2012
Lyn-dependent signaling regulates the innate immune response by controlling dendritic cell activation of NK cells
Danielle L Krebs, Manreet K Chehal, Alexander Sio, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 27, 2013
Characterization of pathogenic human monoclonal autoantibodies against GM-CSF
Yanni Wang, Christy A Thomson, Lenka L Allan, et al.
Scientific Reports
|
September 23, 2017
Deoxyribonuclease 1 reduces pathogenic effects of cigarette smoke exposure in the lung
Paul T King, Roleen Sharma, Kim M O'Sullivan, et al.
The Medical Journal of Australia
|
November 16, 2025
The CURE Asthma roadmap
Gary P Anderson, Anthony Flynn, Phil G Bardin, et al.
The Journal of Allergy and Clinical Immunology
|
October 13, 2018
CSF3R/CD114 mediates infection-dependent transition to severe asthma
Hao Wang, Meaghan FitzPatrick, Nicholas J Wilson, et al.
Expert Opinion on Drug Discovery
|
May 16, 2025
Generative AI and digital twins: shaping a paradigm shift from precision to truly personalized medicine
Maria Bordukova, Alina J Arneth, Nikita Makarov, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 5, 2016
Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema
Saleela M Ruwanpura, Louise McLeod, Lovisa F Dousha, et al.
The Journal of Allergy and Clinical Immunology
|
January 2, 2023
Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma
Gabriele Matschiner, Mary F Fitzgerald, Ulrich Moebius, et al.
The European Respiratory Journal
|
February 26, 2021
Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort
Helen K Reddel, Jørgen Vestbo, Alvar Agustí, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 129) with videos related to
Sort By:
Page
of 13
The Journal of Experimental Medicine
|
September 5, 2002
Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response
Matthias Ernst, Melissa Inglese, Glen M Scholz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 12, 2012
Lyn-dependent signaling regulates the innate immune response by controlling dendritic cell activation of NK cells
Danielle L Krebs, Manreet K Chehal, Alexander Sio, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 27, 2013
Characterization of pathogenic human monoclonal autoantibodies against GM-CSF
Yanni Wang, Christy A Thomson, Lenka L Allan, et al.
Scientific Reports
|
September 23, 2017
Deoxyribonuclease 1 reduces pathogenic effects of cigarette smoke exposure in the lung
Paul T King, Roleen Sharma, Kim M O'Sullivan, et al.
The Medical Journal of Australia
|
November 16, 2025
The CURE Asthma roadmap
Gary P Anderson, Anthony Flynn, Phil G Bardin, et al.
The Journal of Allergy and Clinical Immunology
|
October 13, 2018
CSF3R/CD114 mediates infection-dependent transition to severe asthma
Hao Wang, Meaghan FitzPatrick, Nicholas J Wilson, et al.
Expert Opinion on Drug Discovery
|
May 16, 2025
Generative AI and digital twins: shaping a paradigm shift from precision to truly personalized medicine
Maria Bordukova, Alina J Arneth, Nikita Makarov, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 5, 2016
Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema
Saleela M Ruwanpura, Louise McLeod, Lovisa F Dousha, et al.
The Journal of Allergy and Clinical Immunology
|
January 2, 2023
Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma
Gabriele Matschiner, Mary F Fitzgerald, Ulrich Moebius, et al.
The European Respiratory Journal
|
February 26, 2021
Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort
Helen K Reddel, Jørgen Vestbo, Alvar Agustí, et al.
Page
of 13